Espandar Ladan, O'Brien Susan, Thirkill Charles, Lubecki Linda A, Esmaeli Bita
Section of Ophthalmology, Unit 441, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
J Neurooncol. 2007 Jul;83(3):295-302. doi: 10.1007/s11060-006-9326-7. Epub 2007 Jan 25.
We herein report a patient with cancer-associated retinopathy who experienced multiple bouts of paraneoplastic retinopathy and optic neuropathy but responded to treatments with alemtuzumab and was able to maintain useful vision over the course of 8 years of follow-up.
我们在此报告一名患有癌症相关性视网膜病变的患者,该患者经历了多次副肿瘤性视网膜病变和视神经病变,但对阿仑单抗治疗有反应,并在8年的随访过程中能够维持有用视力。